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Bradykinin Involvement in the 
Aggravation of Acute 
Pancreatitis in Rabbits 
Abstract 
This study was designed to investigate the role of bradykinin in the aggrava-
tion of acute pancreatitis. After inject ion ofbradyk in in 2 Jlg/kg to a nest het izecl 
rabbits with cerulein-induced acute pancreatitis. the pancreatic blood llow 
through gastroduodenal and superior mesenteric arterie~ (GOAF and SM \f) 
was determined with electromagnetic blood OO\\ meters. the serum amylase 
level was measured. and pancreatic tissue was observed histologically. In rab-
bits treated with a supramaximal dose of cerulein alone (20 )..lg/kg/h). pan-
creatic blood llow was decreased and the scrum amylase level was increased 
signilican tly by the early phase. and histological examination showed acute 
edematous pancreatitis. In rabbits treated with cerulcin and bradykinin, 
GDAF and SMAF were signilicantly diminished at 300 m in (51 ± 5% and 50 
± 4%. respectivcl). p < 0.05). and the scrum amylase le' cl rose signilicantly at 
180 and 300 min (730 ± 130% and 1,190 ± 200%. respectively, p < 0.01) 
compared with rabbits treated with cerulein alone, and histological examina-
tion revealed pancreatic necrosis and greater inllammatory cell inliltration. 
These lindings suggest that bradykinin has an additive role in the aggravation 
of acute pancreatitis. 
Kallikrein exists as inactivated prekallikrcin in man y 
tissues and body fluids. such as the salivary glands, kid-
neys. urine. plasma. stomach, small intestine. thyroid 
gland. and pancreas. Kallikrein is classilied as plasma or 
glandular kallikrein. The former is a basic protein \\hich 
releases bradykinin (BK) from high-molecular-weight kin-
inogen, and the latter is an acidic protein which releases 
Lys-BK (kallidin) from high- and low-molecular-weight 
kininogens. Kinin (BK. Lys-BK. and Met-Lys-BK) me-
diates acute inflammation: it increases \·ascular perme-
ability and induces vasodilatation and pain (1]. The kalli-
krein-kinin system has been considered to be involved in 
many clinical diseases. including essential hypertension 
[2]. pulmonaf) edema [3]. bronchial asthma (4]. endotox-
in shock [5]. liver cirrhosis. acute 'iral hepatitis [6]. and 
rheumatoid arthritis [7]. Since the pancreas contains glan-
dular kallikrein and is able to release kinin [8], the kalli-
krein-kinin system is believed to be involved in the 
inflammatory process of acute pancreatitis. 
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It is known that pancreatic ischemia is an initiating or 
promoting factor of acute pancreatitis, and systemic he-
modynamics and pancreatic blood flow are impaired dur-
ing acute pancreatitis [9, 10]. Various vasoactive sub-
stances or chemical mediators such as histamine [11]. 
serotonin [ 12]. myocardial depressant factor [ 13], prosta-
glandins [14], free radicals [15, 16], platelet-activating 
factor [ 17], and kinin [ 18] have been proposed as respon-
sible agents in the hemodynamic and morphological 
changes in pancreatic tissue. It has been reported that kin-
in-forming enzyme, which is present in plasma and ascitic 
fluid. induces hypotension during severe acute pancreati-
tis [19]. 
However, the role of the kallikrein-kinin system on 
pancreatic blood flow during acute pancreatitis has not 
been clarified. The present study was designed to investi-
gate the effect of BK on the aggravation of acute pancre-
atitis by measuring pancreatic blood flow after the injec-
tion of BK to rabbits with cerulein-induced acute pancre-
atitis. 
Materials and Methods 
Twenty male white rabbits weighing 2- 2.7 kg were fasted for 24 h 
and ancsthet ized with intravenous sodium pentobarbital (30 mg/kg). 
Tracheostomy was performed. and they were ventilated mechanical-
ly with room air (IS mllkg x 12/min). During the experiment. physi-
ological saline was infused continuously through an external jugular 
vein (3 mllkg/h) while anesthesia was maintained by the intravenous 
infusion of sodium pentobarbital (7.5 mg/kg/h). A catheter inserted 
into a femoral artery was connected to a pressure-transducer for the 
recording of mean arterial pressure (MAP). Two heparinized poly-
ethylene tubes were inserted into the femoral veins for the infusion of 
ccrulein (Ccosunin injection: Kyowa Hakko. Tokyo, Japan) and bra-
dykinin (BK) (bradykinin acetate salt: Sigma. St. Louis. Mo .. USA). 
and abdominal midline incision was performed. 
The gastroduodenal artery (GDA) and the superior mesenteric 
artery (SMA) were exposed, and non invasive probes ( 1.0-2.5 mm in 
diameter) of electromagnetic blood llow meters (MFV-2100. 3100: 
Nihonkoden. Tokyo. Japan) were placed around them tor the mea-
surement of blood llow (GDAF and SMAF). A polycthylcne tube 
(PE-50: Bccton Dickinson, Parsippanny. N.J .. USA) was inserted 
extraduodenally into the pancreatic duct and fixed. Pancreatic juice 
volume (PJV) was measured every IS min by a fraction collector 
(Model2 11 0: Bio-Rad. Richmond, Calif., USA). 
After a period of about 30 min for stabilization. PJV, MAP, 
GDAF. and SMAF were recorded as basal values. and blood was 
drawn for the measurement of basal pancreatic enzyme activities. 
The rabbits were divided into the following tour groups: (I) control 
group (no ccrulcin. no BK: n = 5). physiological saline. I mllkg was 
infused instead of BK: (2) BK group (n = 5). BK was dissolved 
in saline and 2 pg/kg was injected intravenously: (3) ccrulcin group 
(n = 5). cemlein. 20 pg/kg/h. was infused intravenously for S h. 
and (4) ccmlein-plus-BK group (n = 5). BK 2 ~tg/kg was injected 
when the ccrulcin inJeCtion. 20 pg/kglh. \\a~ started. 
llemod} namics were recorded conttnuousl} for 5 h and blood 
samples were taken from an external Jugular vein 30. 60. 180. and 
300 m in after the ~tart of the mjection. Blood samples were centri-
fuged at 1.600 g. and the plasma was pooled and stored at hclO\\ 
- 40° C until assayed. Scrum amylase activity was determmcd spec-
trophotometrically b} the blue-starch method [20] and lipase ac!lvity 
b) the enz~ mat ic method [2 I]. Tissue was taken from the pancreas 
after 5 h of infusion and fixed with I 0% neutral fom1alin. embedded 
in paraflin and stained with hcmatoxylin and eosin tor histological 
examination. Scmiquantitative analysis of the histological findings 
was performed. Interstitial edema was scored as follows: 0 = absent: 
I = interlobular space was expanded: 2 = interacinar space was 
expanded. and 3 = individual acini \\Cre separated. lnllammator) 
cell infiltration: 0 = absent: I = mild: 2 = moderate. and 3 = severe. 
Acinar cell vaeuolizat ion: 0 = absent: I = <20%: 2 = 20-50%. and 3 = 
>50% of acinar cells with cytoplasmic vacuolcs in the examined area. 
Parenchyma! necrosis: 0 = absent: I = focal (<5%): 2 = sublobular 
(5-20%). and 3 = lobular (>20%). 
Values of P JV. scrum enzyme activities and hemodynamics were 
expressed as percentages of the basal value. and ptesented as the 
mean .l stamlard enur (SE). ami anal) Led by unc-wa) analysis uf 
variance. The histological score was presented as the mean ± SE and 
analyzed by the U test according to Wilcoxon. Mann and Whitney. A 
p < 0.05 was considered to be significant. 
Results 
Light-microscope examination of pancreatic tissue 
from rabbits treated with BK alone showed no significant 
difference from the control group. Histological changes in 
the ceru lein group were interacinar and interlobular ede-
ma, acinar cell vacuolization, inflammatory cell infiltra-
tion in the interlobular edematous space, and minimal 
cell necrosis, demonstrating acute edematous pancreati-
tis. However, these findings were less marked than those 
in rats with cerulein-induccd acute pancreatitis (lig. I A). 
In the cerulein-plus-BK group, necrosis was present and 
inflammatory cell infiltration was more marked. These 
findings proved that BK together with cerulein caused 
and aggravated acute pancreatitis (fig. I B, table I). 
No significant change of PJV was noted in the BK 
group. ln the cerulein and cerulein-plus-BK groups, P JV 
decreased significantly starting in the early phase, demon-
strating disturbed pancreatic exocrine secretion (at 
IS m in: cerulein. 66 ± 8°AJ, p < 0.0 I; cerulein plus BK, 71 
± 6%. p < 0.05; control, 96 ± 4%; and 20 ± 9% and 24 
± 5% at 300 min; control, 92 ± 10%; p < 0.0 1). There 
was no significant difference between the two groups 
(fig. 2). 
Serum amylase levels were compared in the cerulein, 
control and BK groups. They were increased significantly 
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Fig. 1. H istolog~ of the pancreas 5 h after 
starting inject ion of cerulem (20 ~tg/kglh) 
alone (A) and ccrulcin (20 j.tg/kglh) plus BK 
(2 ~tg/kg) (8 ). t\1arked interstitial eth:ma 11 ith 
acinar cell vacuoliLation and inflam matory 
cell in lilt rat ion is found in the cerulein alone 
group. Parenchyma) necrosis is present and 
inflammatory cell inliltration is more 
marked in the ccrulem-plus-BK group. 
Table 1. 11 istological changes 
Group Interstitial Acinar cell Inflammatory Parenchyma I 
cdema vacuolization cell infiltration necrosis 
Control (n = 5) 0 0 0 0 
BK (n = 5) 0 0 0 0 
Cerulein (n = 5) 2- 3 1-2 1-2 0-1 
(2.2 ± 0.2) (1.6 ±0.2) (1.2±0.2) (0.2± 0.2) 
Cerulcin + BK (n = 5) 1- 3 1- 2 1- 3 1- 3 
(1.8±0.4) (1.4±0.2) (2.0±0.3) (2.2 ± 0.4)* 
Each l'alue represents the mean ± SE. * p < 0.05 vs. the ccrulcin group. 
at 30 min in the cerulein group (156 ± 17%; control: 108 
± 4%; BK: 100 ± 3%; p<O.OI). In thecerulein-plus-BK 
group, they were even higher, and at 180 min the differ-
ence from the ceru lei n group was significant (730 ± 
120%; cerulein: 436 ± 35%; p < 0.0 1), and at 300 min 
they reached the highest level ( 1.190 ± 200%: p < 0.0 I). 
There was no significant difference between the control 
and the BK group (fig. 3). 
In all the groups. serum lipase levels changed almost in 
parallel with the serum amylase levels. In the cerulein 
group, they were significantly increased at 30 m in (256 ± 
43%; control: 82 ± 4%, p < 0.05: BK: 78 ± 14%. p < 
0.01 ), and reached a peak of 822 ± 69% at 300 m in (con-
trol : 95 ± 25%; BK: 80 ± 20%; p < 0.01 ). In the cerulein-
pl us-BK group. they were higher than in the cerulei n 
group at 60 min (660 ± 80%; cerulein: 402 ± 73%; p < 
0.0 I), and I ,330 ± 170% at 300 m in (p < 0.0 1 ). MAP in 
both the cerulein and the cerulein-pl us-BK group de-
creased gradually; in the cerulein group it was significant-
ly lower than in the control and BK group at 300 min 
(data not shown). 
In the cerulein group GDAF fell sign ifica ntly more, by 
degrees. than in the control and BK groups: at 30 m in, 82 
± 5% (control: 101 ± 3%, p < 0.05; BK: 117 ± 8%, p < 
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Fig. 2. Changes in PJV every I 5 min. Re-






















Fig. 3. Changes in scrum amylase level. 
Results arc expressed as the mean ± SE. 
0.01) and at 300 min . 67 ± 3% (control: 80 ± 4%, p < 
0.05; BK: 83 ± 4%, p < 0.05). In the cerulein-plus-BK 
group, GDAF, instead of fa ll ing, was significantly higher 
than in the cerulein group at 30-60 m in, because of the 
vasodilatory effect of BK, but then it decreased signifi-
cantly more than in the cerulein group to 51 ± 5% at 
300 min (p < 0.05; fig. 4). 
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Similarly, SMAF in the ccrulein group was significant-
ly diminished as early as 30 m in (78 ± 5%; control: 98 ± 
4%; p < 0.05) and fell to 64 ± 41Yo at 300 m in (control: 83 
± 21Vo; p < 0.05). In the ccrulein-plus-BK group, SMAF 
was significantly higher than in the cerulein group from 
30 min (99 ± 6%. p < 0.05) to 120 min (87 ± 5%, p < 
0.05). but at 300 min it had fallen significantly to 50 ± 
4% (p < 0.05: fig. 5). 
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Fig. 4 . Changes 111 GDi\r. R~.:sulls arc 
cxprcs~cJ as the mean ± SE 
Fig. 5. Changes in SMi\1 . Results arc Cl.-































The pancreas is one or the organs most susceptible to 
ischemia. and it has been shown that pancreatic ischemia 
plays an tmportant role in the initiation and aggravation 
of experimental and clinical acute pancreatitis [10, 22].Jn 
experimental pancreatitis. pancreatic blood now is dimin-
ished along with lowered systemic blood pressure. cardiac 
output and oxygen consumption starting in the earl) stage 
[23. 24]. It has been suggested that impaired pancreatic 
blood llow comes from systemic circulatory disturbances 
due to hypovolemia, disseminated intravascular coagula-
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tion. myocardial depressant factor, or toxic substances in 
the plasma and ascitic fluid [25-27]. And various vasoac-
tive substances, including kinin, have been proposed to be 
involved in the pancreatic circulatory disturbance and to 
lead to the development of acute pancreatitis. 
It has been shown that BK, probably glandular kalli-
krein. is released from the pancreas into the portal vei n 
during acute pancreatitis [28]. BK acts on the cardiovas-
cular system, and its vasodilating potency is about I O-f old 
that of histamine [29]. BK has a direct effect on vascular 
smooth muscle which results in rapidly decreased systolic 
and diastolic blood pressure [30], tachycardia. and in-
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creased cardiac output. Jn this study we attempted to 
determine whether BK aggravates ccrulein-induced acute 
pancreatitis in anesthetized rabbits. An intravenously in-
jected supramaximal dose of20 ~Lg/kg/h of cerulein for 5 h 
significantly disturbed pancreatic exocrine secretion, di-
minished pancreatic blood flow, and elevated serum pan-
creatic enzyme levels in the early phase in anesthetized 
rabbits. Histological examination 5 h after starting the 
cerulein injection showed acute interstitial edematous 
pancreatitis. Thus, acute edematous pancreatitis was in-
duced by a supramaximal dose of cerulein in anesthetized 
rabbits. ln this study, blood pressure quickly decreased 
and pancreatic blood flow increased immediately after 
the injection ofBK, 2 J..Lg/kg (data not shown). In the ceru-
lein-plus-BKgroup, pancreatic blood flow through GDAF 
and SMAF were better maintained than in the ceru lein 
group in the early phase, at 60 m in and at 120 min. How-
ever, pancreatic blood now was significantly lower in the 
late phase, at 300 m in, than in the cerulein group. 
has a direct effect on pancreatic acinar cells. BK is a key 
enzyme in the activation of phospholipase A2 and gener-
ates prostaglandins together with platelet-activating fac-
tor from biomembrane phospholipids [3 1]. Induced pros-
taglandins and leukotrienc activate leukocytes, cause va-
soconstriction or vasodilation, and increase vascular per-
meability [32]. It has been reported that the increase in 
vascular permeability caused by BK is about 15-fold that 
caused by histamine since BK also stimulates emigration 
of the lcukocytes [33]. It is possible that free radicals and 
platelet-activating factor are generated in the activated 
leukocytes and injured vascular endothelial cells, result-
ing in pancreatic injury. The blood coagulation system 
activated by BK, and vascular endothelial cell injury 
caused by free radicals or platelet-activating factor may 
produce microthrombi in the microcapillaries. which can 
induce pancreatic necrosis. 
In the cerulein-plus-BK group, the serum amylase level 
was significantly higher than in the cerulein group at 
180 m in, and histological examination showed marked 
pancreatic necrosis and inflammatory cell infiltration in 
addition to interstitial edema and acinar cell vacuoliza-
tion in the cerulein group. These results suggest that BK 
In conclusion, in the present study, intravenously in-
jected BK in rabbits with cerulcin-induced pancreatitis 
significantly diminished pancreatic blood flow, increased 
pancreatic enzyme levels. and aggravated histological 
findings, indicating aggravation of acute pancreatitis. 
Thus, BK appears to play an important role in the aggra-
vation of acute pancreatitis. 
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